Exagen Inc. Files Q1 2025 10-Q Report
Ticker: XGN · Form: 10-Q · Filed: May 5, 2025 · CIK: 1274737
| Field | Detail |
|---|---|
| Company | Exagen Inc. (XGN) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-laboratories
TL;DR
Exagen Inc. dropped its Q1 2025 10-Q. Check financials.
AI Summary
Exagen Inc. filed its 10-Q for the period ending March 31, 2025. The filing covers financial information and operational updates for the first quarter of 2025. Specific financial figures and business developments are detailed within the report.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational status of Exagen Inc., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information that could reveal significant positive or negative trends impacting the company's stock.
Key Players & Entities
- EXAGEN INC. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250505 (date) — Filing date
- VISTA, CA (location) — Company headquarters location
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 5, 2025.
What is the company's primary business classification?
The company is classified under SERVICES-MEDICAL LABORATORIES [8071].
What is the company's state of incorporation?
Exagen Inc. is incorporated in Delaware (DE).
What was the previous name of Exagen Inc.?
The former company name was EXAGEN DIAGNOSTICS INC, with a name change date of December 30, 2003.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding EXAGEN INC. (XGN).